While GLP-1 medications like Ozempic don’t directly interact with alcohol, experts say drinking can intensify side effects and complicate conditions such as diabetes or pancreatitis
Gina Jansheski, M.D., is a pediatrician with 22 years of practice experience. Dr. Jansheski completed her medical education at the University of Arizona College of Medicine, followed by a pediatric residency and a one-year fellowship in Developmental and Behavioral Pediatrics. She served as the medical director of Tucson Pediatric Hospitalists, providing pediatric hospice and palliative care services.
Ozempic, Wegovy, Rybelsus. These brand-name medications all contain semaglutide, a glucagon-like peptide-1 (GLP-1) agonist. Collectively, GLP-1 drugs can help treat a wide range of medical conditions, from diabetes to obesity.
According to a 2025 poll from the health policy information organization KFF, about 1 in 8 U.S. adults have taken GLP-1s at some point in their lives. If that includes you, and you find yourself having a drink every now and then, it’s helpful to know that moderate alcohol use has been shown to be safe for most people taking Ozempic and similar drugs.
Still, mixing medications with alcohol always comes with risks.
Drinking alcohol while taking Ozempic is generally safe, says Marc-Andre Cornier, M.D., director of Endocrinology, Diabetes, and Metabolic Diseases at the Medical University of South Carolina. “There’s no known direct interaction between GLP-1s and alcohol,” he explains.
However, there may be reasons to limit alcohol use if you take Ozempic. Here’s what to watch for:
This guidance also applies to Mounjaro and Zepbound. These medications contain the active ingredient tirzepatide, which works similarly to semaglutide and other GLP-1s.
It’s possible. Semaglutide and tirzepatide may reduce alcohol intake in some adults taking these medications for obesity (without diabetes). But more research is needed before any conclusions can be made. Still, Dr. Cornier notes he sees this with his patients. “They’re telling me they used to drink a glass of wine at night and now they don’t feel like it anymore,” he says.
Semaglutide is also being studied for the treatment of alcohol use disorder (AUD). Anil Makam, M.D., an internal medicine physician at the University of California, San Francisco, notes that GLP-1s may be a future therapeutic option for people with substance use disorders. “There’s a lot of promise for these medications in treating AUD, but we don’t have enough research yet to know for sure,” he says.
If you’re taking Ozempic, Mounjaro or other GLP-1 drugs, you can drink the occasional glass of wine or cocktail more safely with these tips:
DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.
While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual’s medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.
Help fund our fight for improved medication safety and transparency by supporting our independent journalism.
Give NowIndependent, science-based journalism delivered directly to your inbox.
We seek to create a world where there are safer medications for all and where all people are fully informed about their medication benefits and side effects, using our explanatory and investigative journalism to both inform and stimulate public discussion to drive toward solutions.
Want to hear expert insights about medication safety and other care options? Watch all our past webinars and sign up for upcoming ones.
WATCH NowNo comments yet. Be the first to comment!